首页> 美国卫生研究院文献>Journal of Orthopaedic Surgery and Research >Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies
【2h】

Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies

机译:比较两种经FDA批准的治疗腰椎管狭窄症的棘突间垫片:Superion与X-STOP-来自五项随机对照试验研究的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDecompressive laminectomy (DI) is a standard operation for lumbar spinal stenosis (LSS) patient with severe claudication symptoms for many years. However, patients whose symptom severity does not meet undergoing invasive surgery make therapeutic options into dilemma. Interspinous spacers (ISP) bridge the gap between surgical interventions and CC in management of LSS. In our study, we aim to systematically assess the two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP.
机译:背景减压椎板切除术(DI)是多年来患有严重c行症状的腰椎管狭窄(LSS)患者的标准手术。但是,症状严重程度未达到侵入性手术的患者使治疗选择陷入困境。椎间间隔物(ISP)弥补了LSS管理中手术干预与CC之间的差距。在我们的研究中,我们旨在系统地评估两种FDA批准的棘突间垫片治疗腰椎管狭窄症:Superion与X-STOP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号